-
EAU 2025 | Professor Alicia K. Morgans: Challenges and Breakthroughs in Prostate Cancer Treatment
UroStream: What are the current challenges in clinical practice for metastatic prostate cancer, and what breakthroughs have been achieved recently? Dr. Alicia K. Morgans: I think some of the biggest…
-
IHCAMS 2025 | International Workshop on Cell Therapy for Blood Diseases: Applications Now Open for Belt and Road Traineeship in Tianjin
An international event focusing on cellular therapy for blood diseases is approaching! From August 17 to Sep 1, 2025, in Tuanbo Campus,Tianjin, China, the International Workshop on Cell Therapy of…
-
EAU 2025 | Professor Anders Kjellman: Biopsy Before Treatment Plays a Key Role in Managing Small Renal Masses (SRMs)
Current Clinical Landscape: Biopsy Remains Underused in Small Renal Masses Despite advancements in imaging and surgical techniques, biopsy remains underutilized in the diagnosis of small renal masses (SRMs, ≤4 cm).…
-
CUDA Yanqi Lake Meeting | Professor Liqun Zhou: Advancing the Diagnostic Frontier to Improve Survival in Chinese Prostate Cancer Patients
In recent years, the incidence of prostate cancer in China has continued to rise, creating an urgent need to improve diagnostic and treatment strategies tailored to this growing patient population. At the 5th Annual CUDA Yanqi Lake Meeting (2025), hosted by the Chinese Urological Doctor Association, UroStream invited Professor Liqun Zhou, Institute of Urology, Peking…
-
EAU 2025 | Professor Renée C.A. Leenen Presents 20-Year ERSPC Follow-Up, Offering New Perspectives on Prostate Cancer Screening
UroStream: You shared the long-term follow-up data of the prostate cancer screening study at the EAU conference. Could you please share the main findings? What implications does this study bring…
-
CUDA Yanqi Lake Meeting | Professor Weijun Qin: Xenotransplantation Offers Lifesaving Hope for High-Risk Patients—A Breakthrough Led by China’s Origin
Confronted with the challenge of key immunosuppressive drugs being unavailable in China, the team drew on over a decade of research to develop an innovative, China-specific immunotherapy protocol. The patient,…
-
CUDA Yanqi Lake | Prof. Wasilijiang Wahafu: Novel ADCs Transform First-Line Treatment of Advanced Urothelial Carcinoma
UroStream: Chemotherapy has long been the backbone of treatment for advanced urothelial carcinoma, yet many unmet needs persist. Based on your clinical experience, could you share why cisplatin-based chemotherapy is…
Connecting Medical Expertise through Media
